Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database

The present study investigated the effects of plasma matrix metalloproteinases (MMPs) on longitudinal changes in Alzheimer's disease (AD)-related biomarkers in cerebrospinal fluid (CSF), brain atrophy, and cognitive function in patients with mild cognitive impairment due to AD (MCI-AD).

Source: Journal of the Neurological Sciences - June 21, 2020 Category: Neurology Authors: Kie Abe, Yuhei Chiba, Saki Hattori, Asuka Yoshimi, Takeshi Asami, Omi Katsuse, Akira Suda, Akitoyo Hishimoto, Alzheimer's Disease Neuroimaging Initiative Source Type: research